Clinical Trial Update: Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating HRS-8080 or SHR-A2009 in combination with anti-tumor therapy for unresectable or metastatic breast cancer is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HRS-8080
• SHR-A2009

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING